Literature DB >> 8456059

Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.

P Canale1, F Squadrito, B Zingarelli, D Altavilla, M Ioculano, G M Campo, A P Caputi.   

Abstract

This study was designed to assess the role of leukocytes in rats subjected to splanchnic artery occlusion for 45 min followed by reperfusion (SAO shock). Leukopenia was induced by an intravenous injection of vinblastine (1 mg/kg) 72 h before SAO shock. Survival rate (within 6 h), plasma levels of thromboxane B2 (TxB2), serum levels of tumour necrosis factor (TNF-alpha), and histological alteration of the intestinal tract were investigated. Control rats [white blood cells (WBC) = 10362 +/- 630/mm3] died within 2 h following ischaemia and reperfusion. Leukopenic (WBC = 1263 +/- 311/mm3) animals which underwent SAO shock survived more than 2 h and 50% of them were still alive after 6 h. Plasma TxB2 levels significantly increased in WBC count normal rats subjected to SAO shock (8.4 +/- 2.1 ng/ml), compared to sham animals (0.4 +/- 0.08 ng/ml); however SAO shock raised TxB2 levels significantly less (2.1 +/- 1.1 ng/ml) in leukopenic rats. Serum TNF-alpha, undetectable in sham-shocked rats (either with normal WBC count or without), rose up to 150 +/- 12 U/ml in shocked rate and to 45 +/- 5 U/ml (P < 0.01) in shocked animals with leukopenia. SAO shock induced a massive necrosis of the intestinal tract in rats with normal WBC count. Leukopenia prevented ileum necrosis in SAO shock. These data indicate that leukocytes play an important role in splanchnic artery occlusion and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456059     DOI: 10.1006/phrs.1993.1006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Authors:  D Altavilla; F Squadrito; L Ammendolia; G Squadrito; G M Campo; P Canale; M Ioculano; C Musolino; A Alonci; A Sardella; G Urna; A Saitta; A P Caputi
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

2.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

3.  Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.

Authors:  F Squadrito; D Altavilla; P Canale; M P Ioculano; G M Campo; L Ammendolia; G Squadrito; A Saitta; G Calapai; A P Caputi
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.

Authors:  F Squadrito; D Altavilla; L Ammendolia; G Squadrito; G M Campo; A Sperandeo; P Canale; M Ioculano; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

5.  Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats.

Authors:  B Zingarelli; F Squadrito; P Graziani; R Camerini; A P Caputi
Journal:  Agents Actions       Date:  1993-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.